NEUMORA THERAPEUTICS INC (NMRA)

US6409791000 - Common Stock

2.48  +0.31 (+14.29%)

Premarket: 2.49 +0.01 (+0.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/A
531.73%		N/A
112.57%		N/A
85.03%		N/A
58.53%		N/A
43.75%
EBITDA
YoY % growth
-20K-25.39M
-126,850.00%		-79.78M
-214.22%		-122.28M
-53.27%		-187.526M
-53.36%		N/A
-52.84%		N/A
3.91%		N/A
1.85%		N/A
40.23%		N/A
161.43%		N/A
222.61%		N/A
68.90%		N/A
37.38%
EBIT
YoY % growth
-20K-25.5M
-127,400.00%		-80.32M
-214.98%		-122.87M
-52.98%		-188.194M
-53.17%		N/A
-49.56%		N/A
-7.36%		N/A
-11.95%		N/A
25.51%		N/A
69.10%		N/A
350.30%		N/A
215.15%		N/A
67.20%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/AN/A
7.92%		N/A
-3.37%		N/A
-3.55%		N/A
36.17%		N/A
91.14%		N/A
1,621.33%		N/A
154.61%		N/A
51.28%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.45
36.17%		-0.46
-36.50%		-0.46
-23.36%		-0.44
2.53%		-0.43
6.03%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-81.6M
-65.08%		-78.132M
-30.40%		-80.988M
-27.53%		-85.374M
-12.08%		-91.902M
-12.63%
EBIT
Q2Q % growth		-75.319M
-50.34%		-82.926M
-38.04%		-85.17M
-33.45%		-88.332M
-15.25%		-82.416M
-9.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.45
60.53%		-0.40-0.05-13.12%
Q2 2024
Q2Q % growth		 -0.37 -0.380.012.34%
Q1 2024
Q2Q % growth		 -0.34 -0.350.012.53%
Q4 2023
Q2Q % growth		 -0.71 -0.56-0.15-26.56%
Q3 2023
Q2Q % growth		 -1.14 -0.37-0.77-208.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -12.76% 0% -7.96%
RevenueN/A N/A N/A N/A